Cartesian Therapeutics
RNAC
RNAC
68 hedge funds and large institutions have $119M invested in Cartesian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
30
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$11.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$7.69M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
$12.9M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$3.96M |
| 5 |
6CM
683 Capital Management
New York
|
$2.24M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Acadian Asset Management
Boston,
Massachusetts
| – | -$28K | -1,761 | Closed |
|
|
AAP
77
Arax Advisory Partners
Denver,
Colorado
| – | -$194 | -12 | Closed |
|